Current Medical Research and Opinion

Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score ≥ 24 points - data from the ropinirole clinical trial programme
pp. 1867-1877(11)
Authors: Giorgi, Luigi; Ritchie, Sally Y.; Kirsch, Jeffrey M.

Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form
pp. 1879-1892(14)
Authors: Conley, Robert; Gupta, Suneel K.; Sathyan, Gayatri

A pharmacokinetic study investigating the rate of absorption of a 500 mg dose of a rapidly absorbed paracetamol tablet and a standard paracetamol tablet
pp. 1893-1897(5)
Authors: Ibáñez, Y.; Rodríguez, J.M.; Luján, M.; Grattan, T.J.; Martin, A.J.; Burnett, I.

Comments and reply on The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries
pp. 1899-1902(4)
Authors: Soto, Javier; Holmstrom, Stefan; Buchholz, Patricia; Walt, John; Wickstrøm, Jannie; Aagren, Mark

Assessing the total costs of blood delivery to hospital oncology and haematology patients
pp. 1903-1909(7)
Authors: Agrawal, Samir; Davidson, Neville; Walker, Mel; Gibson, Sian; Lim, Christina; Morgan, Christopher L.l.; Cowell, Warren

painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain
pp. 1911-1920(10)
Authors: Freynhagen, Rainer; Baron, Ralf; Gockel, Ulrich; Tölle, Thomas R.

Effect of gliclazide modified release on adiponectin, interleukin-6, and tumor necrosis factor-α plasma levels in individuals with type 2 diabetes mellitus
pp. 1921-1926(6)
Authors: Drzewoski, Jozef; Zurawska-Klis, Monika

Comments on Initial experience with teriparatide in the United States
pp. 1927-1927(1)
Authors: Harper, Kristine D.; Krege, John H.; Marcus, Robert; Mitlak, Bruce H.

Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa
pp. 1929-1937(9)
Authors: Lefebvre, Patrick; Vekeman, Francis; Sarokhan, Brenda; Enny, Christopher; Provenzano, Robert; Cremieux, Pierre-Yves

Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes
pp. 1939-1947(9)
Authors: Herman, Gary A.; Bergman, Arthur; Yi, Bingming; Kipnes, Mark; The Sitagliptin Study 012 Group,

Clinical equivalence of IV paracetamol compared to IV dipyrone for postoperative analgesia after surgery for breast cancer
pp. 1949-1954(6)
Authors: Kampe, Sandra; Warm, Mathias; Landwehr, Susanne; Dagtekin, Oguzhan; Haussmann, Sascha; Paul, Matthias; Pilgram, Barbara; Kiencke, Peter

Effect on blood pressure control of switching from valsartan monotherapy to losartan/hydrochlorothiazide in Asian patients with hypertension: results of a multicentre open-label trial
pp. 1955-1964(10)
Authors: Watanabe, Luis A.; Wei, Meng; Sun, Ningling; Kim, Dongsoo; Chiang, Chern-En; Ke, Yuannan; Tseng, Chuen-Den; Coloma, Ricardo; Vala, M.; Massaad, R.; Feig, P.; Guptha, S.

Evaluating hospital costs in type 2 diabetes care: does the choice of the model matter?
pp. 1965-1971(7)
Authors: Gregori, D.; Pagano, E.; Rosato, R.; Bo, S.; Zigon, G.; Merletti, F.

Effect of growth hormone treatment on trunk fat accumulation in adult GH-deficient Japanese patients: a randomised, placebo-controlled trial
pp. 1973-1979(7)
Authors: Chihara, Kazuo; Kato, Yuzuru; Takano, Kazue; Shimatsu, Akira; Kohno, Hitoshi; Tanaka, Toshiaki; Irie, Minoru

Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women
pp. 1981-1996(16)
Authors: Somkuti, Stephen G.; Schertz, Joan C.; Moore, Marva; Ferrande, Lee; Kelly, Eduardo; The Gonal-F Prefilled Pen in OI Study 24785 Group,

Comparison of the adverse event profiles of levofloxacin 500 mg and 750 mg in clinical trials for the treatment of respiratory infections
pp. 1997-2006(10)
Authors: Khashab, Mohammed M.; Xiang, Jim; Kahn, James B.

Exogenous endoscopy-related infections, pseudo-infections, and toxic reactions: clinical and economic burden
pp. 2007-2021(15)
Authors: Seoane-Vazquez, Enrique; Rodriguez-Monguio, Rosa; Visaria, Jay; Carlson, Angeline

Preference for monthly darbepoetin alfa dosing in patients with chronic kidney disease not receiving dialysis
pp. 2023-2030(8)
Authors: Hoggard, Jeffrey; Crouch, Thomas; McMurray, Stephen; Levine, Michael; Prathikanti, Radha; Scarlata, Debra; Audhya, Paul

Repetitive dihydroergotamine nasal spray for treatment of refractory headaches: an open-label pilot study
pp. 2031-2036(6)
Author: Weintraub, James

Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia
pp. 2037-2039(3)
Authors: Daskalopoulou, Stella S.; Mikhailidis, Dimitri P.

Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients
pp. 2041-2053(13)
Authors: Catapano, Alberico L.; Davidson, Michael H.; Ballantyne, Christie M.; Brady, William E.; Gazzara, Russell A.; Tomassini, Joanne E.; Tershakovec, Andrew M.

Economic implications of growth hormone use in patients with short bowel syndrome
pp. 2055-2063(9)
Authors: Migliaccio-Walle, Kristen; Caro, J. Jaime; Möller, Jörgen

Self-reported chronic conditions and EQ-5D index scores in the US adult population
pp. 2065-2071(7)
Authors: Ko, Yu; Coons, Stephen Joel

The effect of moxifloxacin on the normal human cornea
pp. 2073-2080(8)
Authors: Donaldson, Kendall E.; Marangon, Fabiana B.; Schatz, Lauren; Venkatraman, Anna S.; Alfonso, Eduardo C.